The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 165:261, February 2008
doi: 10.1176/appi.ajp.2007.07101621
© 2008 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by RASIMAS, J.J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by RASIMAS, J.J.

Letter to the Editor

Treatment of Psychosis in Lewy Body Disease

J.J. RASIMAS, M.D., Ph.D.
Bethesda, Md.

To The Editor: Considering their experience in the management of advanced Lewy body disease (1), it was surprising that in their review of the challenging convergence of neuropsychiatric comorbidity, published in the October 2007 issue of the Journal, Daniel Weintraub, M.D., and Howard I. Hurtig, M.D., (2) omitted electroconvulsive therapy (ECT)—a treatment that can address both psychosis and movement disorder and avoid a host of medication-related side effects without coupling improvement in one realm of symptoms with exacerbation of the other. Along the lines of other potentially beneficial interventions supported by clinical experience but lacking definitive evidence from scientific trials, perhaps a note pertaining to antipsychotic response to serotonin (5-HT3) antagonist ondansetron in such cases should be included as well (3).

Footnotes

Dr. Rasimas reports no competing interests.

This letter (doi: 10.1176/appi.ajp.2007.07101621) was accepted for publication in November 2007.

References

  1. Chou KL, Hurtig HI, Jaggi JL, Baltuch GH, Pelchat RJ, Weintraub D: Electroconvulsive therapy for depression in a Parkinson’s disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism Relat Disord 2005; 11:403–406[CrossRef][Medline]
  2. Weintraub D, Hurtig HI: Presentation and management of psychosis in Parkinson’s disease and dementia with Lewy bodies. Am J Psychiatry 2007; 164:1491–1498[Free Full Text]
  3. Zoldan J, Friedberg G, Livneh M, Melamed E: Psychosis in advanced Parkinson’s disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology 1995; 45:1305–1308[Abstract/Free Full Text]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by RASIMAS, J.J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by RASIMAS, J.J.


Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org